Skip to main content

Information about funding opportunities related to the novel coronavirus (COVID-19) will be added to this page as they become available.

Please contact Nathan Blouin for more information or to report additional opportunities.

Date PostedDeadlineTitleFunding Agency
2022, March 1With Foundation GrantsWith Foundation
2021, March 82022, August 1Emerging Infectious Disease and Preparedness GrantSociety for Academic Emergency Medicine
2022, January 312022, August 25Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional)NIMH/NIH/DHHS
2022, April 252022, August 26 [LOI/Pre-App]The RADx-UP CDCC Rapid Research Pilot ProgramRADx-UP Coordination and Data Collection Center (CDCC)
2022, April 252022, August 26 [LOI/Pre-App]RADx-Up Community Collaboration Mini-Grant ProgramRADx-UP Coordination and Data Collection Center (CDCC)
2022, January 212022, July 5Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated CoagulopathyNHLBI
2021, December 32022, July 6Combatting COVID-19 Grant ProgramU.S. Mission to Canada
2022, May 32022, July 18Equitable and Just Covid-19 Recovery GrantsMeyer Foundation
2022, April 112022, June 1Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Epidemiologic Studies of Diabetes Incidence and Severity and Its Potential Association with COVID-19NIDDKD/NIH/DHHS
2020, March 202022, June 5Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)NIH/NCI/NIDCR
2021, December 212022, June 5Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)NIH/DHHS
2022, April 42022, June 5Notice of Special Interest (NOSI) - Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual DisabilitiesNIH/DHHS
2022, April 212022, June 5Notice of Special Interest (NOSI): Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual DisabilitiesNIH/DHHS
2022, April 252022, June 5Notice of Special Interest (NOSI): Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual DisabilitiesNIH/DHHS
2022, May 32022, June 5Notice of Special Interest (NOSI): Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAANIAAA
2022, April 42022, June 6Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their CommunitiesNIEH
2022, April 182022, June 13Medical Education Grant: Treatment of Acute SARS-CoV-2 Infection and Management of Post-COVID Conditions in Outpatient SettingsPfizer Pharmaceuticals
2022, April 42022, May 1NAN Clinical Research GrantsNAN
2022, April 42022, May 2Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)NIH/DHHS
2022, April 42022, May 2Emergency Awards: RADx®-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)NIH/DHHS
2022, March 82022, May 4US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory SettingsDHHS/CDC
2022, January 8 (Updated March 20, 2022)2022, May 7NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)NIBIB
2022, April 182022, May 13Surveillance of Acutely Ill Adults with Respiratory Viruses, including SARS-CoV-2CDC/DHHS
2022, April 182022, May 13Surveillance of Acutely Ill Adults with Respiratory Viruses, including SARS-CoV-2CDC/DHHS
2022 February 192022, May 25Notice of Special Interest (NOSI): Health Services Research on Health System and Healthcare Professional Responsiveness to COVID-19AHRQ
2020, September 20 (Updated March 20, 2022)2022, November 17Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)NIMH/NIAAA/NIH
2022, April 42022, October 13 [Optional] [LOI/Pre-App
May 31, 2022
Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)NIMH/NIH/DHHS
2020, February 32023, February 3FCO--AMENDMENT --- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency AnnouncementDepartment of Health & Human Services
2022, December 22023, January 26Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional)NIH/DHHS
2020, December 232023, June 1Notice of Special Interest (NOSI): Administrative Supplements for COVID-19 Impacted NIMH ResearchNational Institute of Mental Health/NIH/DHHS
2021, February 32024, August 16Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health NeedsNational Center for Advancing Translational Sciences/NIH/DHHS
2021, February 262024, August 16Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health NeedsNational Center for Advancing Translational Sciences/NIH/DHHS
Continuous SubmissionDuke Energy GrantsDuke Energy
Continuous SubmissionInnovation FundComcast
2018, October 3Continuous SubmissionUrgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement -  Clinical Trial Optional)National Institutes of Health/DHHS
2020, April 2Continuous SubmissionNotice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (Defunct)National Institutes of Health/DHHS
2020, March 10Continuous SubmissionEmergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)National Institutes of Health/DHHS
2020, October 9Continuous SubmissionAdministrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)National Institutes of Health/DHHS
2021, July 11Continuous SubmissionLimited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) National Institute of Allergy and Infectious Diseases/NIH/DHHS
VariableMedical Education Grants: Outpatient Management of COVID-19Pfizer Pharmaceuticals
VariableCompetitive Grant Program: Management of Non-Communicable Diseases (NCD) for Health Care ProvidersPfizer Pharmaceuticals
VariableCoalition for Epidemic Preparedness Innovations (CEPI)CEPI
2022, May 232022, June 27Competitive Grant Program: Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science ResearchPfizer Pharmaceuticals
2022, May 232022, August 1Emerging Infectious Disease and Preparedness GrantSociety for Academic Emergency Medicine (SAEM) Foundation
2022, May 232022, July 15D&I Pilot AwardsASPiRE Center